Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 21, Pages 3362
Publisher
MDPI AG
Online
2022-10-26
DOI
10.3390/cells11213362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema
- (2022) David M. Brown et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy
- (2022) Mengmeng Jiang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
- (2022) Charles C Wykoff et al. LANCET
- Vascular adhesion protein-1 and microvascular diabetic complications
- (2022) Alok D. Singh et al. Pharmacological Reports
- Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: A systematic review and meta-analysis
- (2022) James H.B. Im et al. SURVEY OF OPHTHALMOLOGY
- Cytoprotective Effect of Idebenone through Modulation of the Intrinsic Mitochondrial Pathway of Apoptosis in Human Retinal Pigment Epithelial Cells Exposed to Oxidative Stress Induced by Hydrogen Peroxide
- (2022) Maria Elisabetta Clementi et al. Biomedicines
- Proteome Changes Associated with the VEGFR Pathway and Immune System in Diabetic Macular Edema Patients at Different Diabetic Retinopathy Stages
- (2022) Ruyi Han et al. CURRENT EYE RESEARCH
- Faricimab: First Approval
- (2022) Matt Shirley DRUGS
- Investigation of DHA-Induced Regulation of Redox Homeostasis in Retinal Pigment Epithelium Cells through the Combination of Metabolic Imaging and Molecular Biology
- (2022) Giada Bianchetti et al. Antioxidants
- Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians
- (2022) Zongyi Wang et al. Frontiers in Molecular Biosciences
- Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
- (2021) Hyeong Min Kim et al. Pharmaceutics
- Minocycline and doxycycline: More Than Antibiotics.
- (2021) Sher Singh et al. Current Molecular Pharmacology
- Cytoprotective Effects of Punicalagin on Hydrogen–Peroxide–Mediated Oxidative Stress and Mitochondrial Dysfunction in Retinal Pigment Epithelium Cells
- (2021) Maria Elisabetta Clementi et al. Antioxidants
- Emerging therapies and their delivery for treating age‐related macular degeneration
- (2021) Chloe N. Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab
- (2021) Ahmed Howaidy et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- En face image-based classification of diabetic macular edema using swept source optical coherence tomography
- (2021) Atsushi Fujiwara et al. Scientific Reports
- Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy
- (2021) Shruti Sharma Frontiers in Physiology
- Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
- (2021) Tianqin Wang et al. Eye and Vision
- Malfunction of outer retinal barrier and choroid in the occurrence and progression of diabetic macular edema
- (2021) Ştefan Ţălu et al. World Journal of Diabetes
- Port delivery system: a novel drug delivery platform to treat retinal diseases
- (2021) Arshad M. Khanani et al. Expert Opinion on Drug Delivery
- Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
- (2021) Rehan M Hussain et al. Drug Design Development and Therapy
- Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis
- (2021) Hassan Hashemi et al. Seminars in Ophthalmology
- Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema
- (2021) Luisa Frizziero et al. Journal of Clinical Medicine
- Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases
- (2021) Liron Naftali Ben Haim et al. Pharmaceutics
- Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
- (2021) Shiyue Qin et al. Frontiers in Physiology
- Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2021) Nancy M. Holekamp et al. OPHTHALMOLOGY
- NOX inhibition: Pre-clinical and clinical studies in diabetic complications
- (2020) Sofia Urner et al. ANTIOXIDANTS & REDOX SIGNALING
- Risuteganib—a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema
- (2020) Lincoln T. Shaw et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice
- (2020) Serra Arf et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)
- (2020) Adam R. Glassman et al. OPHTHALMOLOGY
- Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration
- (2020) Derek Kunimoto et al. OPHTHALMOLOGY
- Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
- (2020) Hyeong Min Kim et al. Translational Vision Science & Technology
- Inflammatory and angiogenic biomarkers in diabetic retinopathy
- (2020) Snježana Kaštelan et al. Biochemia Medica
- Emerging drugs for the treatment of diabetic retinopathy
- (2020) Elio Striglia et al. EXPERT OPINION ON EMERGING DRUGS
- Anti-Integrin therapy for retinovascular diseases
- (2020) Ashay D. Bhatwadekar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway
- (2020) Dandan Liu et al. LIFE SCIENCES
- A Custom-Made Semiautomatic Analysis of Retinal Nonperfusion Areas After Dexamethasone for Diabetic Macular Edema
- (2020) Lisa Toto et al. Translational Vision Science & Technology
- Erythropoietin protects the inner blood–retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy
- (2020) Hai Xie et al. DIABETOLOGIA
- A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model
- (2020) Finny Monickaraj et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Erythrocyte membrane fluidity as a marker of diabetic retinopathy in type 1 diabetes mellitus
- (2020) Giada Bianchetti et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Label-free metabolic clustering through unsupervised pixel classification of multiparametric fluorescent images
- (2020) Giada Bianchetti et al. ANALYTICA CHIMICA ACTA
- Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats
- (2020) Valéria Tékus et al. BIOMEDICINE & PHARMACOTHERAPY
- Biosimilars for Retinal Diseases: An Update
- (2020) Ashish Sharma et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
- (2020) Rahul N. Khurana et al. OPHTHALMOLOGY
- Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations
- (2019) Yousof Taghavi et al. Journal of Cell Communication and Signaling
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
- (2019) F. Semeraro et al. DIABETES & METABOLISM
- Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2
- (2019) Rossella Di Stasi et al. MOLECULAR BIOTECHNOLOGY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Treatment of Diabetic Macular Edema
- (2019) Eric J. Kim et al. Current Diabetes Reports
- Innovative therapies for neovascular age-related macular degeneration
- (2019) Hasenin Al-Khersan et al. EXPERT OPINION ON PHARMACOTHERAPY
- OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema
- (2019) Zihan Sun et al. OPHTHALMOLOGY
- Erythropoietin protects outer blood‐retinal barrier in experimental diabetic retinopathy by up‐regulating ZO‐1 and occludin
- (2019) Chaoyang Zhang et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease
- (2019) Rehan M. Hussain et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy
- (2019) Hannah Youngblood et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ilastik: interactive machine learning for (bio)image analysis
- (2019) Stuart Berg et al. NATURE METHODS
- Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro
- (2019) Marina Mesquida et al. Translational Vision Science & Technology
- Pericytes, inflammation, and diabetic retinopathy
- (2019) Benjamin G. Spencer et al. INFLAMMOPHARMACOLOGY
- Reprogramming the metabolome rescues retinal degeneration
- (2018) Karen Sophia Park et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Region-specific ischemia, neovascularization and macular oedema in treatment-naïve proliferative diabetic retinopathy
- (2018) Jason Lange et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
- (2018) Hiroki Mitoma et al. CYTOKINE
- A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema
- (2018) G Srividya et al. EYE
- Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
- (2018) Chloe Peach et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Inflammation in Diabetic Retinopathy
- (2018) Anne Rübsam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of macular edema: Beyond the surface
- (2018) Alejandra Daruich et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy
- (2018) Jianqing Li et al. BMC Ophthalmology
- Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema
- (2018) Jay Chhablani et al. BMC Ophthalmology
- Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy
- (2018) Songfu Feng et al. Journal of Diabetes Research
- Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment
- (2018) Neil M. Bressler et al. JAMA Ophthalmology
- Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine
- (2018) Rosemary E. McDowell et al. DIABETOLOGIA
- Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
- (2018) Rafael Simó et al. DIABETES
- Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells
- (2018) Maria L. Valle et al. EXPERIMENTAL EYE RESEARCH
- Microglia mediate non-cell-autonomous cell death of retinal ganglion cells
- (2018) Akiko Takeda et al. GLIA
- Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy
- (2018) Dong Hyun Jo et al. GLIA
- Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
- (2018) David Callanan et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
- (2018) Ruslan Grishanin et al. MOLECULAR THERAPY
- Metabolomics in the study of retinal health and disease
- (2018) Inês Laíns et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study
- (2018) David J. Valent et al. Translational Vision Science & Technology
- The Anti–Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo
- (2017) Maria Grazia Atzori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Pharmacokinetic aspects of retinal drug delivery
- (2017) Eva M. del Amo et al. PROGRESS IN RETINAL AND EYE RESEARCH
- INCREASED SERUM LEVELS OF UREA AND CREATININE ARE SURROGATE MARKERS FOR DISRUPTION OF RETINAL PHOTORECEPTOR EXTERNAL LIMITING MEMBRANE AND INNER SEGMENT ELLIPSOID ZONE IN TYPE 2 DIABETES MELLITUS
- (2017) Sandeep Saxena et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Novel therapeutic targets in diabetic macular edema: Beyond VEGF
- (2017) Elizabeth A. Urias et al. VISION RESEARCH
- Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium
- (2017) Tina Xia et al. VISION RESEARCH
- Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration
- (2017) Timothy L. Jackson et al. JAMA Ophthalmology
- Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
- (2016) Peter A. Campochiaro et al. Current Diabetes Reports
- Bromfenac Eyedrops in the Treatment of Diabetic Macular Edema: A Pilot Study
- (2016) Antonio Pinna et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression
- (2016) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
- (2016) Elliott H. Sohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The progress in understanding and treatment of diabetic retinopathy
- (2016) Alan W. Stitt et al. PROGRESS IN RETINAL AND EYE RESEARCH
- RETINAL VASCULAR CYSTOID MACULAR EDEMA
- (2016) Richard F. Spaide RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
- (2016) Pedro Romero-Aroca et al. Journal of Diabetes Research
- Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
- (2016) Ian J. Constable et al. EBioMedicine
- Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond
- (2016) Praveen Rao et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Topical dexamethasoneγ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema
- (2015) Akihiro Ohira et al. ACTA OPHTHALMOLOGICA
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes
- (2015) Shruti Sharma et al. MEDIATORS OF INFLAMMATION
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2015) David M. Brown et al. OPHTHALMOLOGY
- Retinal microglia: Just bystander or target for therapy?
- (2015) Marcus Karlstetter et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
- (2015) Rafael Simó et al. PROGRESS IN RETINAL AND EYE RESEARCH
- SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA
- (2015) Stela Vujosevic et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Treatment of Exudative Age-Related Macular Degeneration with a Designed Ankyrin Repeat Protein that Binds Vascular Endothelial Growth Factor: a Phase I/II Study
- (2014) Eric H. Souied et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
- (2014) Steven F. Abcouwer et al. Annals of the New York Academy of Sciences
- Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service
- (2014) Rebecca L Thomas et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
- (2014) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ramucirumab: First Global Approval
- (2014) Raewyn M. Poole et al. DRUGS
- Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
- (2014) Thomas A Ciulla et al. EXPERT OPINION ON PHARMACOTHERAPY
- A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
- (2014) Colin D. Weekes et al. INVESTIGATIONAL NEW DRUGS
- Erythropoietin Exerts a Neuroprotective Function Against Glutamate Neurotoxicity in Experimental Diabetic Retina
- (2014) L. Gu et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
- (2014) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
- (2014) David S. Boyer et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Implants
- (2014) José Cunha-Vaz et al. OPHTHALMOLOGY
- Chemokine Mediated Monocyte Trafficking into the Retina: Role of Inflammation in Alteration of the Blood-Retinal Barrier in Diabetic Retinopathy
- (2014) Sampathkumar Rangasamy et al. PLoS One
- NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
- (2013) Jennifer L. Wilkinson-Berka et al. ANTIOXIDANTS & REDOX SIGNALING
- Reactive Oxygen Species in Inflammation and Tissue Injury
- (2013) Manish Mittal et al. ANTIOXIDANTS & REDOX SIGNALING
- Plasma kallikrein-kinin system and diabetic retinopathy
- (2013) Jia Liu et al. BIOLOGICAL CHEMISTRY
- New functions of Müller cells
- (2013) Andreas Reichenbach et al. GLIA
- SUBVISIBLE RETINAL LASER THERAPY
- (2013) Daniel Lavinsky et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
- (2013) Rafael Simó et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy
- (2012) Carin Gustavsson et al. ACTA OPHTHALMOLOGICA
- Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
- (2012) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study
- (2012) Peter A. Campochiaro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema
- (2012) Ranjan Rajendram et al. ARCHIVES OF OPHTHALMOLOGY
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema
- (2012) Kaoru Tamura et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Diabetic Retinopathy
- (2012) David A. Antonetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- IL-1β Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1β Autostimulation
- (2012) Yang Liu et al. PLoS One
- Treatment of diffuse diabetic macular oedema using steroid eye drops
- (2011) Sakiko Nakano Goto et al. ACTA OPHTHALMOLOGICA
- Tanibirumab (TTAC-0001): A fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2)
- (2011) Sang Hoon Lee ARCHIVES OF PHARMACAL RESEARCH
- Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
- (2011) Carmel M. McVicar et al. DIABETES
- Role of microglia in CNS inflammation
- (2011) Manuel B. Graeber et al. FEBS LETTERS
- Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
- (2011) C-M Lai et al. GENE THERAPY
- Unknown
- (2011) Ismayil Ahmet et al. MOLECULAR MEDICINE
- Physiology of Microglia
- (2011) Helmut Kettenmann et al. PHYSIOLOGICAL REVIEWS
- Inflammation in diabetic retinopathy
- (2011) Johnny Tang et al. PROGRESS IN RETINAL AND EYE RESEARCH
- LONG-TERM SAFETY, HIGH-RESOLUTION IMAGING, AND TISSUE TEMPERATURE MODELING OF SUBVISIBLE DIODE MICROPULSE PHOTOCOAGULATION FOR RETINOVASCULAR MACULAR EDEMA
- (2011) Jeffrey K. Luttrull et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
- (2011) Pankaj Bhargava et al. Current Oncology Reports
- Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in db/db Mice: Role of NADPH Oxidase 4
- (2010) J. Li et al. DIABETES
- Blood-Retinal Barrier
- (2010) José Cunha-Vaz et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells
- (2010) Min Zhao et al. FASEB JOURNAL
- Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema
- (2010) Sakiko Nakano et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—Implications for the Pathogenesis of Diabetic Retinopathy
- (2010) Rafael Simó et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Barrier analysis of periocular drug delivery to the posterior segment
- (2010) Veli-Pekka Ranta et al. JOURNAL OF CONTROLLED RELEASE
- Durezol® (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte® 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis
- (2010) C. Stephen Foster et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intravitreal Erythropoietin Therapy for Patients with Chronic and Progressive Diabetic Macular Edema
- (2010) Weiye Li et al. OPHTHALMIC SURGERY LASERS & IMAGING
- Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells
- (2009) Marta Villarroel et al. EXPERIMENTAL EYE RESEARCH
- Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes
- (2009) Kousuke Noda et al. EXPERIMENTAL EYE RESEARCH
- Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent
- (2009) J Jones et al. EXPERT OPINION ON PHARMACOTHERAPY
- Functional Implication of Dp71 in Osmoregulation and Vascular Permeability of the Retina
- (2009) Abdoulaye Sene et al. PLoS One
- Role of Steroids in the Management of Diabetic Macular Edema and Proliferative Diabetic Retinopathy
- (2009) Paolo S. Silva et al. Seminars in Ophthalmology
- Microglial Activation in Human Diabetic Retinopathy
- (2008) Hui-yang Zeng ARCHIVES OF OPHTHALMOLOGY
- Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy
- (2008) T Oshitari et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
- (2008) Yoshiyuki Ohsugi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Müller retinal glial cell membrane
- (2008) Patrice E. Fort et al. GLIA
- Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain
- (2008) Michael S. Korenfeld et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- Retinal ganglion cells in diabetes
- (2008) Timothy S. Kern et al. JOURNAL OF PHYSIOLOGY-LONDON
- Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
- (2008) M. Brines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological mechanisms in the pathogenesis of diabetic retinopathy
- (2008) Anthony P. Adamis et al. Seminars in Immunopathology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started